8726641

Source:http://linkedlifedata.com/resource/pubmed/id/8726641

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:8726641	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:8726641	lifeskim:mentions	umls-concept:C0087111	lld:lifeskim
pubmed-article:8726641	lifeskim:mentions	umls-concept:C0085652	lld:lifeskim
pubmed-article:8726641	lifeskim:mentions	umls-concept:C0012694	lld:lifeskim
pubmed-article:8726641	lifeskim:mentions	umls-concept:C0332237	lld:lifeskim
pubmed-article:8726641	lifeskim:mentions	umls-concept:C1522168	lld:lifeskim
pubmed-article:8726641	pubmed:issue	3	lld:pubmed
pubmed-article:8726641	pubmed:dateCreated	1996-11-18	lld:pubmed
pubmed-article:8726641	pubmed:abstractText	Pyoderma gangrenosum is an uncommon skin disease usually treated with systemic drugs, most frequently corticosteroids. Isolated topical treatment is usually considered unsatisfactory.	lld:pubmed
pubmed-article:8726641	pubmed:language	eng	lld:pubmed
pubmed-article:8726641	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:8726641	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:8726641	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:8726641	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:8726641	pubmed:issn	1018-8665	lld:pubmed
pubmed-article:8726641	pubmed:author	pubmed-author:BrennerSS	lld:pubmed
pubmed-article:8726641	pubmed:author	pubmed-author:TamirAA	lld:pubmed
pubmed-article:8726641	pubmed:author	pubmed-author:LandauMM	lld:pubmed
pubmed-article:8726641	pubmed:issnType	Print	lld:pubmed
pubmed-article:8726641	pubmed:volume	192	lld:pubmed
pubmed-article:8726641	pubmed:owner	NLM	lld:pubmed
pubmed-article:8726641	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:8726641	pubmed:pagination	252-4	lld:pubmed
pubmed-article:8726641	pubmed:dateRevised	2004-11-17	lld:pubmed
pubmed-article:8726641	pubmed:meshHeading	pubmed-meshheading:8726641-...	lld:pubmed
pubmed-article:8726641	pubmed:meshHeading	pubmed-meshheading:8726641-...	lld:pubmed
pubmed-article:8726641	pubmed:meshHeading	pubmed-meshheading:8726641-...	lld:pubmed
pubmed-article:8726641	pubmed:meshHeading	pubmed-meshheading:8726641-...	lld:pubmed
pubmed-article:8726641	pubmed:meshHeading	pubmed-meshheading:8726641-...	lld:pubmed
pubmed-article:8726641	pubmed:meshHeading	pubmed-meshheading:8726641-...	lld:pubmed
pubmed-article:8726641	pubmed:meshHeading	pubmed-meshheading:8726641-...	lld:pubmed
pubmed-article:8726641	pubmed:meshHeading	pubmed-meshheading:8726641-...	lld:pubmed
pubmed-article:8726641	pubmed:meshHeading	pubmed-meshheading:8726641-...	lld:pubmed
pubmed-article:8726641	pubmed:meshHeading	pubmed-meshheading:8726641-...	lld:pubmed
pubmed-article:8726641	pubmed:year	1996	lld:pubmed
pubmed-article:8726641	pubmed:articleTitle	Topical treatment with 1% sodium cromoglycate in pyoderma gangrenosum.	lld:pubmed
pubmed-article:8726641	pubmed:affiliation	Department of Dermatology, Tel Aviv Sourasky Medical Center, Ichilov Hospital, Israel.	lld:pubmed
pubmed-article:8726641	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:8726641	pubmed:publicationType	Case Reports	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:8726641	lld:pubmed